Literature DB >> 15608841

A case of recurrent erythema multiforme and its therapeutic complications.

P Sen1, S H Chua.   

Abstract

INTRODUCTION: We report a patient with recurrent erythema multiforme (recurrent EM) who developed iatrogenic Cushing's syndrome due to prolonged corticosteroid use. CLINICAL PICTURE: The patient had been treated with multiple courses of oral and intramuscular prednisolone over a 10-year period to suppress his recurrent and episodic symptoms. This resulted in the development of iatrogenic Cushing's syndrome with secondary adrenal suppression and steroid-induced osteoporosis. TREATMENT: The patient was treated with continuous acyclovir therapy in addition to azathioprine. This combination controlled his disease and enabled us to stop his requirement for high-dose prednisolone. OUTCOME: The patient responded well to this treatment regimen and has been in remission to date.
CONCLUSION: This represents a severe case of recurrent EM and the side effects associated with years of chronic high-dose steroid usage. We discuss the therapeutic options to aid physicians in treating this disabling condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15608841

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  4 in total

1.  Oral blistering - report of two cases of erythema multiforme & literature review.

Authors:  Bharati Patil; Sushmini Hegde; Shobha Naik; Rakesh Sharma
Journal:  J Clin Diagn Res       Date:  2013-09-10

2.  A Case Report: Clinical Efficacy of Combination Treatment of Dexamethasone and Azathioprine in Recurrent Erythema Multiforme.

Authors:  Oki Suwarsa; Isabella Puspa Dewi; Endang Sutedja; Hartati Purbo Dharmadji; Hendra Gunawan; Miranti Pangastuti
Journal:  Int Med Case Rep J       Date:  2022-07-06

Review 3.  Current Perspectives on Erythema Multiforme.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

4.  Screening practices for paediatric asymptomatic adrenal suppression in Canada: Are we addressing this important risk?

Authors:  Ellen B Goldbloom; Alexandra Ahmet
Journal:  Paediatr Child Health       Date:  2019-03-30       Impact factor: 2.253

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.